(2R,4R)-2-乙基氨基-4-甲基-5,5-二氧代-5,7-二硫杂双环[4.3.0]壬-8,10-二烯-8-磺酰胺; 杜塞酰胺; 多佐胺-2-6; (2R,4R)-2-乙基氨基-4-甲基-5,5-二氧代-5,7-二硫杂双环(4.3.0)壬-8,10-二烯-8-磺酰胺; 杜塞酰胺; (2R,4R)-2-乙基氨基-4-甲基-5,5-二氧代-5,7-二硫杂双环[4.3.0]壬-8,10-二烯-8-磺酰胺; 多佐胺-2-6; (2R,4R)-2-乙基氨基-4-甲基-5,5-二氧代-5,7-二硫杂双环(4.3.0)壬-8,10-二烯-8-磺酰胺; 杜塞酰胺; (2R,4R)-2-乙基氨基-4-甲基-5,5-二氧代-5,7-二硫杂双环[4.3.0]壬-8,10-二烯-8-磺酰胺; 多佐胺-2-6; (2R,4R)-2-乙基氨基-4-甲基-5,5-二氧代-5,7-二硫杂双环(4.3.0)壬-8,10-二烯-8-磺酰胺
(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide; (4S,6S)-4H-Thieno[2,3-b]thiopyran-2-sulfonamide (4-(ethylamino)-5,6-dihydro-6-methyl; 1cil; Trusopt; MFCD00865636; (2r,4r)-2-ethylamino-4-methyl-5,5-dioxo-5,7-dithiabicyclo[4.3.0]nona-8,10-diene-8-sulfonamide; DORZOLAMIDE(SUBJECTTOPATENTFREE); 4H-Thieno[2,3-b]thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4S,6S)-; 4H-Thieno[2,3-b]thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4S-trans)-; 4S,6S-Dorzolamide; (4S,6S)-4-(ethylamino)-5,6-dihydro-6-methyl-7,; 4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide; (4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide; (4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide; 4H-Thieno[2,3-b]thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4S-cis)-; 4H-Thieno[2,3-b]thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4R-cis)-
room temp
1、 摩尔折射率:75.48 2、 摩尔体积(cm3/mol):211.0 3、 等张比容(90.2K):609.0 4、 表面张力(dyne/cm):69.4 5、 极化率(10-24cm3):29.92
1.疏水参数计算参考值(XlogP):0.4 2.氢键供体数量:2 3.氢键受体数量:7 4.可旋转化学键数量:3 5.互变异构体数量:无 6.拓扑分子极性表面积151 7.重原子数量:19 8.表面电荷:0 9.复杂度:534 10.同位素原子数量:0 11.确定原子立构中心数量:2 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1